Africa and its Issues- Why Have We Ignored Africa? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Africa and its Issues- Why Have We Ignored Africa?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: S. maltophilia	11/7/2009 4:27:40 PM
	of 1267

High hopes for a malaria vaccine The makers of Mosquirix announce a trial involving thousands of children in Africa. They aim to seek marketing approval as soon as 2012 and have a vaccine that reduces infections by 80% by 2025. By Thomas H. Maugh II 7:11 PM PST, November 6, 2009 Each year, malaria kills more than 1 million people -- 90% of them in sub-Saharan Africa and 80% of them younger than 5 -- and makes 300 million people seriously ill. Major progress in controlling the disease has been made by the widespread adoption of bed nets to keep mosquitoes from attacking children at night and by the use of artemisinin-based therapy, which is the most effective treatment for infections. But vaccines have historically proved the best technique for controlling infectious diseases, and researchers have high hopes for a new one called RTS,S/AS2A, or Mosquirix. A massive trial of it is underway in Africa, with 5,000 children ........... latimes.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next